Discontinuation report HUMULIN N
Report ID | 156217 |
Drug Identification Number | 00587737 |
Brand name | HUMULIN N |
Common or Proper name | insulin isophane, human biosynthetic (rDNA origin) |
Company Name | ELI LILLY CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN NPH HUMAN DNA ORIGIN |
Strength(s) | 100UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | Vial HI0313, 3 mL, 100 units/mL |
ATC code | A10AC |
ATC description | INSULINS AND ANALOGUES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-11-16 |
Actual discontinuation date | 2022-12-07 |
Remaining supply date | 2022-11-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Only the 3 mL vial presentation (Vial HI0313, 3 mL, 100 units/mL) is being discontinued, anticipated remaining supply date may be impacted based on any changes in demand. The following presentations remain available: Humulin N 10 mL, 100 units/mL Vial HI0310 (same DIN 00587737), Humulin N 3.0 mL, 100 units /mL, 5 cartridges/box HI0319 (DIN 01959239), Humulin N 3.0 mL prefilled pen, 100 units/mL, KwikPen HP8805 (DIN 02403447) |
Company comments | Humulin N 3 mL vial presentation shares a DIN with the 10 mL vial presentation (00587737). Humulin N 10 mL vial presentation will continue to be available. For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-03-07 | English | Compare |
v2 | 2022-03-07 | French | Compare |
v3 | 2022-09-02 | English | Compare |
v4 | 2022-09-02 | French | Compare |
v5 | 2022-11-10 | English | Compare |
v6 | 2022-11-10 | French | Compare |
v7 | 2022-11-11 | English | Compare |
v8 | 2022-12-09 | English | Compare |
v9 | 2022-12-09 | French | Compare |
Showing 1 to 9 of 9